Cure My Disease
Don't miss your cure!
Please sign in to follow a disease.
Clinical trials sponsored by F2g Biotech Gmbh, explained in plain language.
This study tests a new drug called olorofim against a standard treatment (AmBisome followed by usual care) for a serious lung infection caused by Aspergillus fungus. About 225 adults with proven or probable infection will take part. The main goal is to see if olorofim reduces dea…
Phase 3 • Sponsor: F2G Biotech GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC